Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev)

Oncotarget
P PastinaPierpaolo Correale

Abstract

Radiotherapy (RT), together with a direct cytolytic effect on tumor tissue, also elicits systemic immunological events, which sometimes result in the regression of distant metastases (abscopal effect). We have shown the safety and anti-tumor activity of a novel metronomic chemotherapy (mCH) regimen with dose-fractioned cisplatin, oral etoposide and bevacizumab, a mAb against the vasculo-endothelial-growth-factor (mPEBev regimen), in metastatic non-small-cell-lung cancer (mNSCLC). This regimen, designed on the results of translational studies, showed immune-modulating effects that could trigger and empower the immunological effects associated with tumor irradiation. In order to assess this, we carried out a retrospective analysis in a subset of 69 consecutive patients who received the mPEBev regimen within the BEVA2007 trial. Forty-five of these patients, also received palliative RT of one or more metastatic sites. Statistical analysis (a Log-rank test) revealed a much longer median survival in the group of patients who received RT [mCH vs mCH + RT: 12.1 +/-2.5 (95%CI 3.35-8.6) vs 22.12 +/-4.3 (95%CI 11.9-26.087) months; P=0.015] with no difference in progression-free survival. In particular, their survival correlated with the m...Continue Reading

References

Mar 28, 2007·Immunology·Ryungsa KimKazuaki Tanabe
May 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giorgio Vittorio ScagliottiDavid Gandara
Sep 17, 2009·Annals of Internal Medicine·Teruhiko TerasawaThomas A Trikalinos
Oct 10, 2009·International Review of Cell and Molecular Biology·Paolo ChieffiGiuseppe Portella
Mar 23, 2010·Cell·Laurence ZitvogelGuido Kroemer
May 4, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Aileen B ChenDeborah Schrag
Aug 2, 2011·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·V Grégoire, T R Mackie
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll
Oct 20, 2012·International Journal of Radiation Oncology, Biology, Physics·Silvia C Formenti, Sandra Demaria
Nov 22, 2012·Journal of Palliative Medicine·UNKNOWN Expert Panel on Radiation Oncology-Bone MetastasesCatherine Van Poznak
Dec 21, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shannon K BromleyAndrew D Luster
Mar 29, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S F SlovinT M Beer
Jul 31, 2013·Journal of the American College of Radiology : JACR·Kenneth E RosenzweigHenning Willers
Dec 21, 2013·Cancer Control : Journal of the Moffitt Cancer Center·Benjamin C Creelan
Jan 3, 2014·The Journal of Clinical Investigation·Liufu DengYang-Xin Fu
Jun 28, 2014·Journal of Palliative Medicine·Simon Shek-Man LoGregory M M Videtic
Aug 8, 2014·The Cancer Journal·Vassiliki A BoussiotisLequn Li
Aug 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen T LutzEdward Chow
Sep 5, 2014·Cancer Immunology Research·Chad TangJames W Welsh
Sep 12, 2014·Journal of Pharmacology & Pharmacotherapeutics·Rituparna Maiti
Mar 11, 2015·Nature·Christina Twyman-Saint VictorAndy J Minn
Mar 11, 2015·Therapeutic Advances in Medical Oncology·Raghav SundarRoss A Soo
Mar 24, 2015·Future Oncology·Julie R BrahmerEvan J Lipson
Jul 3, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·David P CarboneLuis Paz-Ares
Nov 20, 2015·Current Problems in Cancer·Yazan AbuodehSungjune Kim
Nov 28, 2015·Current Problems in Cancer·G Daniel GrassSungjune Kim
May 21, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Antonin LevyEric Deutsch
Jul 1, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S F SlovinT M Beer

❮ Previous
Next ❯

Citations

Mar 28, 2018·Expert Review of Anticancer Therapy·Paolo TiniAntonio Giordano
May 8, 2018·Oncotarget·Marco RossiPierfrancesco Tassone
Aug 29, 2020·Cells·Pierpaolo CorrealePierosandro Tagliaferri
Apr 25, 2019·Journal of Oncology·Cem SimsekSuayib Yalcin
Dec 1, 2020·Critical Reviews in Oncology/hematology·Palma FedeleSaverio Cinieri
Mar 21, 2020·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·Bruce E EllerinJoseph T Martins
Jun 3, 2021·Cancers·Marina Elena CazzanigaMaria Grazia Cerrito

❮ Previous
Next ❯

Software Mentioned

SPSS
Plex Manager
Stat View
Bio

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.